Zosano Pharma
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Zosano Pharma generated cash of -$27,590,000, which is more than the previous year. Cash used in financing activities reached the amount of $8,793,000 last year. Net change in cash is therefore -$24,220,000.
Cash Flow
| 2012 | 501K | 1.98M | -1.11M |
|---|---|---|---|
| 2013 | -3.72M | 1.13M | 3.52M |
| 2014 | -10.91M | -1.13M | 7.34M |
| 2015 | -24.15M | -30.94M | 60.53M |
| 2016 | -25.68M | 30.27M | 3.77M |
| 2017 | -27.11M | -1.22M | 24.99M |
| 2018 | -29.12M | -19.21M | 45.82M |
| 2019 | -34.81M | 2.16M | 29.82M |
| 2020 | -31.71M | -8.48M | 69.15M |
| 2021 | -27.59M | -5.42M | 8.79M |
ZSAN Cash Flow Statement (2012 – 2021)
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 35.71M | 6.77M | 9.59M | 12.10M | 15.00M | 6.64M | 1.21M | 5.91M | 4.97M | 3.6M |
Operating activities | ||||||||||
Net income | -29.92M | -33.36M | -37.58M | -35.35M | -29.10M | -29.83M | -28.42M | -14.24M | -5.60M | 1.81M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 1.75M | 1.42M | 683K | 764K | 2.55M | 2.54M | 2.45M | 3.04M | 428K | 1.06M |
Stock-based compensation expense | 1.9M | 1.58M | 1.61M | 1.17M | 692K | 1.16M | 653K | 184K | 65K | 63K |
| Deferred income tax benefit | 1.9M | 1.58M | 1.61M | 1.17M | 692K | 1.16M | 653K | 184K | 65K | 63K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -110K | 0 | 0 | 0 | 0 | 0 | 111K | 3.31M | 3.33M | 352K |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | -323K | 154K | -532K | 0 |
Accounts payable | 582K | -1.47M | 1.76M | 98K | -34K | 172K | 724K | -2.63M | 265K | -100K |
Cash generated by operating activities | -27.59M | -31.71M | -34.81M | -29.12M | -27.11M | -25.68M | -24.15M | -10.91M | -3.72M | 501K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | -3.47M | -29.78M | -8.28M | 0 | -42.63M | 0 | -365K | 0 |
Investments In Property Plant And Equipment | -5.42M | -8.48M | -11.76M | -5.49M | -1.24M | -287K | -432K | -1.17M | -897K | -21K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 225K | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -5.42M | -8.48M | 2.16M | -19.21M | -1.22M | 30.27M | -30.94M | -1.13M | 1.13M | 1.98M |
Financing activities | ||||||||||
Common Stock Issued | 10.21M | 54.91M | 26.78M | 45.60M | 26.62M | 6.64M | 61.61M | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -2.24M | 0 | -7.35M | 0 | -2.87M | 0 | 0 | 0 | -1.11M |
Cash used in financing activities | 8.79M | 69.15M | 29.82M | 45.82M | 24.99M | 3.77M | 60.53M | 7.34M | 3.52M | -1.11M |
Net Change In Cash | -24.22M | 28.94M | -2.82M | -2.51M | -3.35M | 8.35M | 5.43M | -4.69M | 940K | 1.37M |
Cash at end of period | 11.49M | 35.71M | 6.77M | 9.59M | 11.65M | 15.00M | 6.64M | 1.21M | 5.91M | 4.97M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |